Johnson & Johnson (JNJ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,109,000 | 9,356,000 | 3,749,000 | 15,297,000 | 12,255,000 |
| Depreciation Amortization | 5,193,000 | 3,466,000 | 1,761,000 | 6,929,000 | 5,194,000 |
| Income taxes - deferred | -2,126,000 | -694,000 | -362,000 | -1,016,000 | 53,000 |
| Accounts receivable | -680,000 | -335,000 | 154,000 | -1,216,000 | -1,043,000 |
| Other Working Capital | 3,131,000 | -2,119,000 | -2,704,000 | -28,000 | -3,150,000 |
| Other Operating Activity | 391,000 | -183,000 | 945,000 | 2,235,000 | 2,648,000 |
| Operating Cash Flow | $17,018,000 | $9,491,000 | $3,543,000 | $22,201,000 | $15,957,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 865,000 | 1,525,000 | -403,000 | -467,000 | -1,457,000 |
| Net Acquisitions | -5,562,000 | -5,346,000 | -1,683,000 | -899,000 | -897,000 |
| Purchase Of Investment | -2,684,000 | -1,517,000 | -730,000 | -5,626,000 | -4,155,000 |
| Sale Of Investment | 2,459,000 | 2,132,000 | 1,495,000 | 4,289,000 | 1,162,000 |
| Other Investing Activity | 72,000 | 1,000 | -96,000 | -464,000 | -48,000 |
| Investing Cash Flow | $-4,850,000 | $-3,205,000 | $-1,417,000 | $-3,167,000 | $-5,395,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 148,000 | 15,000 | 13,000 | 80,000 | 40,000 |
| Debt Issued | 1,000 | 1,000 | N/A | 5,000 | 6,000 |
| Debt Repayment | -1,008,000 | -1,005,000 | -1,002,000 | -1,555,000 | -910,000 |
| Common Stock Issued | 580,000 | 463,000 | 94,000 | 949,000 | 480,000 |
| Common Stock Repurchased | -6,320,000 | -4,692,000 | -2,206,000 | -5,868,000 | -2,060,000 |
| Dividend Paid | -7,417,000 | -4,918,000 | -2,396,000 | -9,494,000 | -7,083,000 |
| Other Financing Activity | 73,000 | 86,000 | -19,000 | -2,627,000 | -2,594,000 |
| Financing Cash Flow | $-13,943,000 | $-10,050,000 | $-5,516,000 | $-18,510,000 | $-12,121,000 |
| Exchange Rate Effect | -83,000 | 33,000 | 17,000 | -241,000 | -209,000 |
| Beginning Cash Position | 18,107,000 | 18,107,000 | 18,107,000 | 17,824,000 | 17,824,000 |
| End Cash Position | 16,249,000 | 14,376,000 | 14,734,000 | 18,107,000 | 16,056,000 |
| Net Cash Flow | $-1,858,000 | $-3,731,000 | $-3,373,000 | $283,000 | $-1,768,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,018,000 | 9,491,000 | 3,543,000 | 22,201,000 | 15,957,000 |
| Capital Expenditure | -2,238,000 | -1,493,000 | -656,000 | -3,670,000 | -2,352,000 |
| Free Cash Flow | 14,780,000 | 7,998,000 | 2,887,000 | 18,531,000 | 13,605,000 |